BioCorRx (BICX) Long-Term Deferred Tax (2012 - 2025)

BioCorRx (BICX) has 12 years of Long-Term Deferred Tax data on file, last reported at $13.2 million in Q4 2025.

• Quarterly Long-Term Deferred Tax rose 6.66% year-over-year to $13.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.2 million (up 6.66% YoY) and the FY2025 annual result came in at $13.2 million, up 6.66% from the prior year.
• Long-Term Deferred Tax improved to $13.2 million in Q4 2025 per BICX's latest filing, from $12.3 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $13.2 million in Q4 2025, with the low at $9.4 million in Q4 2021.
• Average Long-Term Deferred Tax over 3 years is $11.6 million, with a median of $12.3 million recorded in 2024.
• Year-over-year, Long-Term Deferred Tax jumped 40.7% in 2021 and rose 6.66% in 2025.
• BioCorRx's Long-Term Deferred Tax stood at $9.4 million in 2021, then soared by 31.86% to $12.3 million in 2024, then grew by 6.66% to $13.2 million in 2025.
• Business Quant data shows BICX's Long-Term Deferred Tax at $13.2 million in Q4 2025, $12.3 million in Q4 2024, and $9.4 million in Q4 2021.